Atorvastatin potentiates the effect of selenomethionine on thyroid autoimmunity in euthyroid women with Hashimoto’s thyroiditis

References

• Hiromatsu Y, Satoh H, Amino N. Hashimoto’s thyroiditis: history and future outlook. Hormones (Athens) 2013;12:12–18
   PubMedGoogle Scholar
• Caturegli P, Kimura H, Rocchi R, et al. Autoimmune thyroid diseases. Curr Opin Rheumatol 2007;19:44–8
   PubMed Web of Science ®Google Scholar
• Gessl A, Lemmens-Gruber R, Kautzky-Willer A. Thyroid disorders. Handb Exp Pharmacol 2012;214:361–86
   PubMedGoogle Scholar
• Köhrle J, Gärtner R. Selenium and thyroid. Best Pract Res Clin Endocrinol Metab 2009;23:815–27
   PubMed Web of Science ®Google Scholar
• Köhrle J. Selenium and the control of thyroid hormone metabolism. Thyroid 2005;15:841–53
   PubMed Web of Science ®Google Scholar
• Duntas LH. Selenium and the thyroid: a close-knit connection. J Clin Endocrinol Metab 2010;95:5180–8
   PubMed Web of Science ®Google Scholar
• Krysiak R, Okopień B. The effect of levothyroxine and selenomethionine on lymphocyte and monocyte cytokine release in women with Hashimoto’s thyroiditis. J Clin Endocrinol Metab 2011;96:2206–15
   PubMed Web of Science ®Google Scholar
• Fan Y, Xu S, Zhang H, et al. Selenium supplementation for autoimmune thyroiditis: a systematic review and meta-analysis. Int J Endocrinol 2014;2014:904573
   PubMedGoogle Scholar
• Toulis KA, Anastasilakis AD, Tzellos TG, et al. Selenium supplementation in the treatment of Hashimoto’s thyroiditis: a systematic review and a meta-analysis. Thyroid 2010;20:1163–73
   PubMed Web of Science ®Google Scholar
• Wichman J, Winther KH, Bonnema SJ, et al. Selenium supplementation significantly reduces thyroid autoantibody levels in patients with chronic autoimmune thyroiditis: a systematic review and meta-analysis. Thyroid 2016;26:1681–99
   PubMed Web of Science ®Google Scholar
• Gartner R, Gasnier B, Dietrich JW, et al. Selenium supplementation in patients with autoimmune thyroiditis decreases thyroid peroxidase antibodies concentrations. J Clin Endocrinol Metab 2002;87:1687–91
   PubMed Web of Science ®Google Scholar
• Anastasilakis AD, Toulis KA, Nisianakis P, et al. Selenomethionine treatment in patients with autoimmune thyroiditis: a prospective, quasi randomised trial. Int J Clin Pract 2012;66;378–83
   PubMed Web of Science ®Google Scholar
• Karanikas G, Schuetz M, Kontur S, et al. No immunological benefit of selenium in consecutive patients with autoimmune thyroiditis. Thyroid 2008;18:7–12
   PubMed Web of Science ®Google Scholar
• Krysiak R, Kowalcze K, Okopień B. The effect of statin therapy on thyroid autoimmunity in patients with Hashimoto's thyroiditis: a pilot study. Pharmacol Rep 2016;68:429–34
   PubMed Web of Science ®Google Scholar
• Krysiak R, Szkróbka W, Okopień B. Moderate-dose simvastatin therapy potentiates the effect of vitamin D on thyroid autoimmunity in levothyroxine-treated women with Hashimoto’s thyroiditis and vitamin D insufficiency. Pharmacol Rep 2017;70:93–7
   PubMed Web of Science ®Google Scholar
• Wu X, Schott M, Liu C, et al. Statins decrease the aberrant HLA-DR expression on thyrocytes from patients with Hashimoto's thyroiditis. Horm Metab Res 2008;40:838–41
   PubMed Web of Science ®Google Scholar
• Gullu S, Emral R, Bastemir M, et al. In vivo and in vitro effects of statins on lymphocytes in patients with Hashimoto's thyroiditis. Eur J Endocrinol 2005;153:41–8
   PubMed Web of Science ®Google Scholar
• Krysiak R, Szkróbka W, Okopień B. The effect of hypolipidemic agents on thyroid autoimmunity in women with Hashimoto’s thyroiditis treated with levothyroxine and selenomethionine. Exp Clin Endocrinol Diabetes 2018;126:321–6
   PubMed Web of Science ®Google Scholar
• Fülöp P, Seres I, Jenei Z, et al. Increased hair selenium concentration in hyperlipidemic patients. J Cell Mol Med 2013;17:350–5
   PubMed Web of Science ®Google Scholar
• Dietrich JW, Müller P, Schiedat F, et al. Nonthyroidal illness syndrome in cardiac illness involves elevated concentrations of 3,5-diiodothyronine and correlates with atrial remodeling. Eur Thyroid J 2015;4:129–37
   PubMed Web of Science ®Google Scholar
• Dietrich JW, Landgrafe-Mende G, Wiora E, et al. Calculated parameters of thyroid homeostasis: emerging tools for differential diagnosis and clinical research. Front Endocrinol (Lausanne) 2016;7:57
   Google Scholar
• Arnaud J, Akbaraly TN, Hininger-Favier I, et al. Fibrates but not statins increase plasma selenium in dyslipidemic aged patients—the EVA study. J Trace Elem Med Biol 2009;23:21–8
   PubMed Web of Science ®Google Scholar
• Krysiak R, Gdula-Dymek A, Okopień B. Effect of simvastatin and fenofibrate on cytokine release and systemic inflammation in type 2 diabetes mellitus with mixed dyslipidemia. Am J Cardiol 2011;107:1010–18
   PubMed Web of Science ®Google Scholar
• Davies JT, Delfino SF, Feinberg CE, et al. Current and emerging uses of statins in clinical therapeutics: a review. Lipid Insights 2016;9:1329
   Google Scholar
• Kiełczykowska M, Kocot J, Paździor M, et al. Selenium - a fascinating antioxidant of protective properties. Adv Clin Exp Med 2018;27:245–55
   PubMed Web of Science ®Google Scholar
• Burek CL, Rose NR. Autoimmune thyroiditis and ROS. Autoimmun Rev 2008;7:530–7
   PubMed Web of Science ®Google Scholar
• Balázs C, Kaczur V. Effect of selenium on HLA-DR expression of thyrocytes. Autoimmune Dis 2012;2012:374635
   PubMedGoogle Scholar
• Chaker L, Bianco AC, Jonklaas J, et al. Hypothyroidism. Lancet 2017;390:1550–62
   PubMed Web of Science ®Google Scholar
• Prummel MF, Wiersinga WM. Thyroid peroxidase autoantibodies in euthyroid subjects. Best Pract Res Clin Endocrinol Metab 2005;19:1–15
   PubMed Web of Science ®Google Scholar
• Ciccone MM, De Pergola G, Porcelli MT, et al. Increased carotid IMT in overweight and obese women affected by Hashimoto's thyroiditis: an adiposity and autoimmune linkage? BMC Cardiovasc Disord 2010;10:22
   PubMed Web of Science ®Google Scholar
• Xiang G, Xiang L, Xiang L, et al. Change of plasma osteoprotegerin and its association with endothelial dysfunction before and after exercise in Hashimoto’s thyroiditis with euthyroidism. Exp Clin Endocrinol Diabetes 2012;120:529–34
   PubMed Web of Science ®Google Scholar
• Stamatelopoulos KS, Kyrkou K, Chrysochoou E, et al. Arterial stiffness but not intima-media thickness is increased in euthyroid patients with Hashimoto’s thyroiditis: the effect of menopausal status. Thyroid 2009;19:857–62
   PubMed Web of Science ®Google Scholar
• Chen WH, Chen YK, Lin CL, et al. Hashimoto’s thyroiditis, risk of coronary heart disease, and L-thyroxine treatment: a nationwide cohort study. J Clin Endocrinol Metab 2015;100:109–14
   PubMed Web of Science ®Google Scholar
• Beaglehole R, Jackson R, Watkinson J, et al. Decreased blood selenium and risk of myocardial infarction. Int J Epidemiol 1990;19:918–22
   PubMed Web of Science ®Google Scholar
• Bor MV, Cevìk C, Uslu I, et al. Selenium levels and glutathione peroxidase activities in patients with acute myocardial infarction. Acta Cardiol 1999;54:271–6
   PubMed Web of Science ®Google Scholar
• Alehagen U, Alexander J, Aaset J. Supplementation with selenium and coenzyme Q10 reduces cardiovascular mortality in elderly with low selenium status. a secondary analysis of a randomised clinical trial. PLoS One 2016;11:e0157541
   PubMed Web of Science ®Google Scholar
• Stranges S, Marshall JR, Trevisan M, et al. Effects of selenium supplementation on cardiovascular disease incidence and mortality: secondary analyses in a randomized clinical trial. Am J Epidemiol 2006;163:694–9
   PubMed Web of Science ®Google Scholar
• Gianoukakis AG, Smith TJ. Recent insights into the pathogenesis and management of thyroid-associated ophthalmopathy. Curr Opin Endocrinol Diabetes Obes 2008;15:446–52
   PubMed Web of Science ®Google Scholar
• Dharmasena A. Selenium supplementation in thyroid associated ophthalmopathy: an update. Int J Ophthalmol 2014;7:365–75
   PubMed Web of Science ®Google Scholar
• Stein JD, Childers D, Gupta S, et al. Risk factors for developing thyroid-associated ophthalmopathy among individuals with Graves disease. JAMA Ophthalmol 2015;133:290–6
   PubMed Web of Science ®Google Scholar
• Kłapcińska B, Poprzecki S, Danch A, et al. Selenium levels in blood of Upper Silesian population: evidence of suboptimal selenium status in a significant percentage of the population. Biol Trace Elem Res 2005;108:1–15
   PubMed Web of Science ®Google Scholar
• Marzec Z. Alimentary chromium, nickel, and selenium intake of adults in Poland estimated by analysis and calculations using the duplicate portion technique. Nahrung 2004;48:47–52
   PubMedGoogle Scholar
• Ambroziak U, Hybsier S, Shahnazaryan U, et al. Severe selenium deficits in pregnant women irrespective of autoimmune thyroid disease in an area with marginal selenium intake. J Trace Elem Med Biol 2017;44:186–91
   PubMed Web of Science ®Google Scholar
• Duntas LH. Selenium and thyroid: a close-knit connection. J Clin Endocrinol Metab 2010;95:5180–8
   PubMed Web of Science ®Google Scholar
• Combs GF Jr. Biomarkers of selenium status. Nutrients 2015;7:2209–36
   PubMed Web of Science ®Google Scholar
• Hurst R, Collings R, Harvey LJ, et al. EURRECA-estimating selenium requirements for deriving dietary reference values. Crit Rev Food Sci Nutr 2013;53:1077–96
   PubMed Web of Science ®Google Scholar
• Szybiński Z; Polish council for control of iodine deficiency disorders. Work of the Polish council for control of iodine deficiency disorders, and the model of iodine prophylaxis in Poland. Endokrynol Polska 2012;63:156–60
   PubMed Web of Science ®Google Scholar